Exova Diagnostics LLC
Exova Diagnostics LLC was paid $39K by Medicaid between Aug 2021 and Aug 2024, across 5 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 80% of everything it billed.
EL PASO, TX 79936
Next to other Clinical Medical Laboratory providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 126 | $10K | |
| 2022 | 390 | $21K | |
| 2023 | 25 | $316.80 | |
| 2024incomplete | 201 | $8K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 80% | 496 | 437 | $31K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 16% | 119 | 96 | $6K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.8% | 68 | 68 | $1K |
| 88312 | 1.5% | 39 | 39 | $585.50 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 20 | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Nova Labs, LLC | Templeton, CA | $74K |
| Blake K Anderson DMD LLC | Grants Pass, OR | $17K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.